Billion dollar pills
An overhaul at Pfizer, the biggest and most conservative of drugs firms, shows what ails the industry
“DEATH is optional,” says a smiling David Brennan. As an American, he is only half joking about his homeland's demands for a cure for everything. But as chief executive of AstraZeneca, a big British drugs firm, his brimming self-confidence is a reminder of the genuine long-term promise of the pharmaceuticals industry. The world will always need health care—and more and more of it as developed countries grow older and developing nations grow richer. The demand for new drugs can only increase.
This article appeared in the Briefing section of the print edition under the headline “Billion dollar pills”
Briefing January 27th 2007
Discover more
The Adani bribery case could upend Indian business and politics
The allegations against the corporate champion may end up being resolved diplomatically rather than in court
The war in Ukraine is straining Russia’s economy and society
Despite advances on the battlefield, pressure is growing
How will Donald Trump handle the war in Ukraine?
And how will Ukraine, Russia and Europe respond?
Elon Musk’s transformation, in his own words
Our analysis of 38,000 posts on X reveal a changed man
Elon Musk and Donald Trump seem besotted. Where is their bromance headed?
The precedents are not encouraging
The energy transition will be much cheaper than you think
Most analysts overestimate energy demand and underestimate technological advances